FDA approves first oral drug for postpartum depression
It's estimated 1 in 7 women suffer from the condition after giving birth.
Syndicated from the fediverse. Read and engage on the original instance.
View original on kbin.socialhttps://www.washingtonpost.com/health/2023/08/04/fda-approves-postpartum-depression-drug-zurzuvae/Open linkView original on kbin.social
1 reply
Excellent! Such good news! Postpartum depression is really rough.
It's strange though. When I had PPD in my country 5 years ago oral treatment was already a thing.
Hopefully this treatment will be accessible to mothers with PPD and not locked away by high cost.